DEENOVA
16.1.2023 06:01:50 CET | Business Wire | Press release
Deenova confirms its undisputed leadership on the French Hospital Pharmacy Automation market by announcing six new contract awards in France of 10 market leading D3 ACCED mechatronic solutions through the previous victory at competitive UNIHA tender. Three have been awarded by both the Centre Hospitalier de Béziers and the Centre Hospitalier de Troyes, one has been awarded by the Etablissement public départemental de santé de Gorze, by the Etablissement public de santé mentale de l’Aube at Brienne-Le- Château, by the Centre Hospitalier Alpes-Leman at Contamine-sur-Arve, and finally by the Hôpital de Sallanches.
Loïc Bessin, Managing Director of Deenova France, proudly stated: “This is the best way to start 2023, and confirms our undisputed leadership in France. More than 50 healthcare institutions have chosen our robots, because of their reliability, speed and ease of use. We expect this trend to continue and even accelerate as the demand for solution to secure medication is growing significantly.”
Christophe Jaffuel, Chief Commercial Officer of Deenova, said: “I am extremely proud of the results of our French organization, that has been scoring 3 years of record sales consecutively. France has been a major contributor to the European revenue growth of the company, together with successful market entries in Germany, Spain, UK and Poland.”
The Centre Hospitalier de Béziers is part of the Groupement Hospitalier de Territoire Ouest-Hérault, in the Occitanie region of southern France, providing emergency assistance, surgical and medical specialties, psychological support and screenings.
Gorze is a commune of the Grand Est Region in north-eastern France and the Etablissement public départemental de santé has 310 beds.
In the Grand Est Region there is also the Etablissement public de santé mentale de l’Aube at Brienne-Le- Château, an adult psychiatric clinic with day hospital, geronto psychiatry beds and a medium term unit receiving prisoners.
Centre Hospitalier de Troyes is in the capital of the Aube department and has 11 centers covering all medical, surgical and medico-technical disciplines, with more than 1,000 beds.
Contamine-sur-Arve is a commune in the Auvergne-Rhône-Alpes region of eastern France. The Centre Hospitalier Alpes-Leman has 700 beds and places with more than 2,000 professionals assisting 1,300 people every day.
The Hôpital de Sallanches is one of the 5 sites of the Hôpitaux du Pays du Mont Blanc, all located in the heart of 3 worldwide famous ski areas, at the foot of Mont-Blanc, in the Haute-Savoie department. More than 1,000 health professionals working in 6 committed poles, from Surgery & Acute Care to Geriatrics, provide health coverage to 120,000 permanent inhabitants and many seasonal tourists.
Deenova is the undisputed leading supplier of combined mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere. Deenova’s unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff. Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%.
Please visit www.deenova.com for additional information on its market leading solutions.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230115005028/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Darktrace Selects Navan to Modernise Travel Program25.2.2026 10:00:00 CET | Press release
Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced it has been selected by Darktrace, a global leader in AI for cybersecurity, to upgrade its global travel program. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260225522665/en/ Darktrace Selects Navan to Modernise Travel Program “As Darktrace accelerates its expansion, in-person collaboration is critical,” said David Smith, Chief People Officer at Darktrace. “Navan’s inventory and user experience will ensure our teams and customers can easily connect, while we can maintain financial control.” As the UK-based cybersecurity company grows, Darktrace sought a partner to consolidate its travel operations, minimize administrative burden, and improve the booking experience for its workforce. Previously hampered by fragmented processes, Darktrace required a solution that would increase platform adoption and empower its employees to tra
AI: The New Insider Threat Facing Organizations25.2.2026 09:00:00 CET | Press release
Thales 2026 Data Threat Report Finds 70% of Organizations Rank AI as Top Data Security Risk As AI systems gain broader access to enterprise data across environments, organizations must treat data visibility and encryption as core security elements. AI-enabled deepfakes and misinformation are increasing the effectiveness of identity-based attacks. Today, credential theft is the leading attack technique against cloud infrastructure (67%). Nearly 60% of companies report deepfake-driven incidents, and 48% experience damage from AI-generated misinformation Investment in AI security is growing, with 30% of companies allocating dedicated budgets; however, 53% are still relying on existing security budget According to the Thales 2026 Data Threat Report, organizations across various markets including automotive, energy, finance and retail say the rapid pace of AI-driven transformation is now their biggest security challenge. Based on the report’s research, conducted by S&P Global 451 Research,
Zuper and Vonage Reimagine Network Connectivity for Skilled Trades with Quality on Demand25.2.2026 09:00:00 CET | Press release
Zuper to receive early access to Vonage Quality on Demand network API, for high-stakes field workflows - ensuring reliable network performance for live video, wearables, and inspections across industries like HVAC, electrical, general construction, roofing, manufacturing, and more Zuper, the AI operating system for the trades, and Vonage, part of Ericsson, have entered into a Memorandum of Understanding (MoU) to enter into a collaboration to integrate Vonage’s network APIs into the Zuper platform. The collaboration will provide Zuper with early access to Vonage network powered solutions, starting with Quality on Demand (QoD), where mobile network performance can be selectively applied to support critical field workflows, delivering improved latency, reliability, and connected experiences for mobile workforces. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260225852261/en/ QoD is the first advanced network API being integrat
Industrial Decarbonization: Calderion, WenCo and Terravent Invest in Graforce to Scale Plasma Pyrolysis Globally25.2.2026 08:07:00 CET | Press release
The investor consortium comprising the Paris-based Next Generation Fuels Industrial & Technological fund Calderion (Audacia), alongside infrastructure developer Terravent and WenCo Family Office, announces the closing of a strategic double-digit million-euro financing round for Berlin-based Graforce GmbH. The investment is dedicated to the industrial scale-up of Graforce’s proprietary plasma pyrolysis technology, addressing the growing global demand for cost-efficient low-carbon hydrogen, syngas, and carbon removal solutions that are compatible with existing industrial infrastructures. Disruptive alternative to conventional processes Graforce’s technology aims at replacing CO₂-intensive legacy routes such as steam reforming and classical gasification. By applying plasma to methane, biogas, flare gas, and landfill gas, the process converts these streams into their valuable molecular components instead of emitting them. The result is a high-efficiency production of clean hydrogen and syn
Mevion Medical Systems Announces CE Marking of the MEVION S250-FIT™ Proton Therapy System, Expanding Global Access to Compact Proton Therapy25.2.2026 08:00:00 CET | Press release
CE Marking enables marketing and clinical use of the world’s first and only LINAC vault-ready proton therapy system across the European Union Mevion Medical Systems, the global leader in compact proton therapy, today announced that the MEVION S250-FIT Proton Therapy System has successfully completed the conformity assessment process and has received CE Marking under Regulation (EU) 2017/745 (EU MDR). This regulatory milestone enables the marketing, sale, and clinical use of the MEVION S250-FIT system throughout the European Union, building on the system’s existing U.S. FDA 510(k) clearance granted in September 2025. The MEVION S250-FIT is the first and only proton therapy system designed to fit into a standard radiation therapy vault. By enabling cancer centers to use their existing infrastructure, the MEVION S250-FIT dramatically reduces the cost, complexity, and timeline traditionally associated with proton therapy adoption. This opens a new pathway for hospitals and cancer centers a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom